Most people who take Paxlovid notice some symptom relief within 24 to 48 hours of the first dose. By days 3 to 5 of treatment, the majority feel significantly better compared to when they started. But the drug works best when you start it as early as possible, ideally within the first five days of your symptoms appearing.
What Happens in the First Few Days
Paxlovid works by blocking an enzyme the virus needs to copy itself inside your cells. Once you take the first dose, the drug begins interfering with viral replication relatively quickly, though you won’t feel the effects immediately. The virus doesn’t stop causing symptoms the moment it stops multiplying. Your body still needs time to clear out the viral particles already produced and calm the immune response that’s driving your fever, body aches, and fatigue.
That’s why the typical pattern looks like this: mild improvement around day 1 or 2 of treatment, then noticeably feeling better by days 3 to 5. The full course is five days, taken twice daily, and most people finish the course feeling substantially recovered. This doesn’t mean you’re necessarily testing negative by then, but your symptoms should be trending clearly downward.
Why Starting Early Matters So Much
Paxlovid must be started within five days of your first symptoms. This isn’t an arbitrary cutoff. Early in a COVID infection, the virus is replicating rapidly and your body hasn’t yet mounted its full immune defense. The drug’s job is to slam the brakes on that replication before the virus causes enough damage to land you in the hospital. Once the disease has progressed past that early viral phase, stopping replication helps less because the damage is already underway.
The practical takeaway: if you test positive and you’re eligible, don’t wait to see if you get worse. The evidence confirms that starting treatment when viral loads are high, early in the disease course, provides the most benefit. Even if your symptoms feel mild at first, beginning treatment promptly gives the drug its best chance of keeping things that way.
How You Take It
The standard dose is three tablets twice a day: two pink tablets (the active antiviral) plus one white tablet (a booster that keeps the antiviral at effective levels in your bloodstream). That’s six pills total per day, split between a morning dose and a bedtime dose, for five days. People with kidney problems may receive a reduced dose of four pills per day instead. You can take Paxlovid with or without food.
The white booster tablet is important to understand because it’s the reason Paxlovid interacts with so many other medications. It slows down a liver enzyme that breaks down dozens of common drugs, which means those drugs can build up to higher levels in your body. Your prescriber will review your medication list before writing the prescription.
Who Is Eligible
Paxlovid is approved for adults with mild to moderate COVID who are at high risk of getting seriously ill. The list of qualifying risk factors is broader than many people realize. It includes diabetes, a BMI over 25, chronic lung disease (including asthma), chronic kidney disease, heart disease, high blood pressure, active cancer, being a current smoker, or having a weakened immune system. Adults 60 and older qualify regardless of other health conditions.
It is not approved for preventing COVID before or after exposure, and it’s not indicated for people without any risk factors for severe disease.
How Effective It Is Against Current Variants
Paxlovid targets the virus’s internal replication machinery rather than the spike protein that mutates most frequently, which is why it has held up well against newer variants. A large study published by the NIH found that among adults 50 and older infected with Omicron variants, those who took Paxlovid had a 44% lower risk of hospitalization or death compared to those who didn’t. For unvaccinated people in that group, the risk reduction was even larger at 81%.
Overall hospitalization rates from COVID have dropped well below 1%, so the absolute numbers are small. But for someone in a high-risk category, cutting that already-low risk nearly in half is meaningful.
Paxlovid Rebound
About 1 in 5 people who take Paxlovid experience what’s called rebound, where symptoms return after the five-day course ends. The leading theory is straightforward: while you’re taking the drug, it suppresses viral replication so effectively that your immune system doesn’t fully finish the job. Once the drug clears your system, leftover virus can briefly flare up and cause symptoms again.
Rebound is generally mild and resolves on its own within a few days. It doesn’t mean the drug failed. The initial course still provided its primary benefit of preventing severe illness during the critical early window. If you notice symptoms returning a few days after finishing treatment, you’re likely experiencing this phenomenon rather than a new infection.